The European Union officially banned eight categories of AI systems it considers too dangerous to exist. The United States, meanwhile, has done roughly nothing at the federal level to match that effort.

The EU AI Act, which entered into force on August 1, 2024, started enforcing its “unacceptable risk” prohibitions on February 2, 2025. It’s the world’s first comprehensive AI regulatory framework, and it draws a bright line around practices like cognitive manipulation, social scoring, and emotion recognition in workplaces and schools.

What Europe actually banned

The prohibited categories include social scoring systems that rank citizens based on behavior, AI that manipulates people in ways likely to cause physical or psychological harm, and emotion recognition technology deployed in schools or workplaces.

The ban on “unacceptable risk” systems is just the opening act. High-risk AI obligations, which cover many healthcare applications, have enforcement deadlines extending from August 2026 to December 2027 or later. The EU recently published interpretative guidelines specifically targeting prohibited healthcare practices.

The US approach: move fast, regulate never

As of mid-2026, the United States still lacks a comprehensive federal AI regulatory framework. The prevailing philosophy has been to let innovation run and trust the private sector to self-regulate.

The absence of federal rules doesn’t mean zero oversight. Sector-specific guidelines exist, and individual states have taken their own approaches. But there’s no equivalent to the EU AI Act, no unified list of banned practices, and no federal agency with clear authority to pull the plug on manipulative AI systems.

Why crypto investors should care

Consider a decentralized AI platform that offers emotion recognition services or behavioral prediction tools. If that platform operates in or serves European users, it now faces a binary choice: comply with the AI Act’s prohibitions or exit the EU market entirely.

European AI firms that already meet the Act’s standards may command trust premiums in the market. Meanwhile, US-based projects operating in regulatory gray zones carry hidden risk that current token prices may not fully reflect.

When Europe’s high-risk healthcare AI obligations kick in over the next 18 months, the impact will ripple through every AI-adjacent crypto project with medical or wellness applications.